In gastric cancer, the proliferation of cancer cells is inhibited by miR-135a via inactivation of JAK2/STAT3 and targeting cyclin D1, Bcl-xl40, kinesin family member C141 and the focal adhesion kinase (FAK) pathway45. Here, JAK2 is linked to cancer.